Bayesian Capital Management »

Travere Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $398k 28k 13.99
2024-03-31 $177k 23k 7.71
2023-06-30 $457k 30k 15.36